DNAStar | GenomeWeb


The I-TASSER software is a multi-year winner of the Critical Assessment of Protein Structure Prediction challenge.

Enzymatics has launched version 3.0 of its Archer Analysis Pipeline. It's the latest incarnation of the company's next-generation sequence analysis platform for detecting and characterizing cancer-causing gene fusions and mutations from clinical samples.

CollabRx has launched CancerRx, a new oncology application that runs on Apple's operating system. The app provides oncologists and pathologists with treatment options that are based on their patients' tumors and also offers a daily newsfeed from MedPage Today.

NEW YORK (GenomeWeb) – DNAStar said this week that it has received a $150,000 Small Business Innovation Research grant from the National Institutes of Health's fast track award program to support the first phase of its efforts to improve and expand NovaFold, its cloud-based protein structure and

DNAStar said this week that the National Institute of Animal Biotechnology (NIAB) in Hyderabad, India, has licensed its Lasergene software for sequence assembly and analysis.

DNAStar said this week that Northwestern University has signed an agreement that will allow the company to provide its Lasergene software suite to all faculty, staff, and students at the institution.

DNAStar said this week that ShrimpEX Biotech Services, an Indian biotechnology company, has selected its Lasergene software for sequence assembly and analysis.

DNAStar said this week that the Wellcome Trust Sanger Institute has licensed its Lasergene software for primary sequence assembly and analysis.
The financial details of the arrangement were not disclosed.

DNAStar has added SeqMan NGen and SeqMan Pro applications to BaseSpace Apps, Illumina's store for cloud-based bioinformatics applications.


In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.